Nonpharmacologic treatment of heart failure in the elderly

Clinics in Geriatric Medicine

Volumn 16, Issue 3, 2000, Pages 477-487

  Lenihan, Daniel J ^a,b   Uretsky, Barry F ^c  

^a Gunderson Lutheran Health System   (United States)

^b STANFORD UNIVERSITY   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; DIURETIC AGENT; FLAVONOID; MAGNESIUM; THIAMINE; UBIQUINONE;

AGED; DIET SUPPLEMENTATION; ELDERLY CARE; HEART FAILURE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIFESTYLE; OUTCOMES RESEARCH; QUALITY OF LIFE; REVIEW; SOCIOECONOMICS; SODIUM RESTRICTION;

EID: 0033886834     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0690(05)70024-0     Document Type: Article

References (62)

1. Self-reported differences between cardiologists and heart failure specialists in the management of chronic heart failure
2. Frequency of low-risk hospital admissions for heart failure
3. The National Roundtable on Health Care Quality: The urgent need to improve health care quality
4. Differences in generalist and specialist physicians' knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure
5. Heart failure survival among older adults in the United States: A poor prognosis for an emerging epidemic in the medicare population
6. Antioxidants and atherosclerotic heart disease
7. Management of heart failure II. Counseling, education, and lifestyle modifications
8. Sudden death as a result of heart disease in morbid obesity
9. Obesity and heart disease: A statement for healthcare professionals from the nutrition committee, American Heart Association
10. Differences between primary care physicians and cardiologists in management of congestive heart failure: Relation to practice guidelines
11. Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q
12. Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure
13. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team
14. Precipitating factors leading to decompensation of heart failure: Traits among urban blacks
15. Effect of a heart failure program on hospitalization frequency and exercise tolerance
16. Physician practice in the management of congestive heart failure
17. Implementing a congestive heart failure disease management program to decrease length of stay and cost
18. Teaching principles and cost of sodium-restricted diets (perspectives in practice)
19. Readmission after hospitalization for congestive heart failure among medicare beneficiaries
20. Quality of care for elderly patients hospitalized with heart failure
21. Is there a role for thiamine supplementation in the management of heart failure?
22. Intermittent inotropic therapy in an outpatient setting: A cost-effective therapeutic modality in patients with refractory heart failure
23. Patterns of angiotensin-converting enzyme inhibitor prescriptions, educational interventions, and outcomes among hospitalized patients with heart failure
24. Importance of abstention from alcohol in alcoholic heart disease
25. Effect of coenzyme Q therapy in patients with congestive cardiac failure: A long term multicenter randomized study
26. Quality of care for patients hospitalized with heart failure at academic medical centers
27. Concomitant factors of decompensation in chronic heart failure
28. Consensus recommendations for the management of chronic heart failure
29. The treatment gap in coronary artery disease and heart failure: Community standards and the post-discharge patient
30. Comprehensive multidisciplinary programs for the management of patients with congestive heart failure
31. Factors determining angiotensin-converting enzyme inhibitor underutilization in heart failure in a community setting
32. Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals
33. Managed care for congestive heart failure: Influence of payor status on process of care, resource utilization, and short-term outcomes
34. Cardiology or primary care for heart failure in the community setting process of care and clinical outcomes
35. A community hospital-based congestive heart failure program: Impact on length of stay, admission and readmission rates, and cost
36. Alcohol and the cardiovascular system
37. Treatment of patients admitted to the hospital with congestive heart failure: Specialty-related disparities in practice patterns and outcomes
38. Wine, alcohol, platelets and the French paradox for coronary heart disease
39. Heart failure disease management: A critical review
40. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure
41. Cost-effectiveness analysis in clinical practice: The case of heart failure
42. Hormones and hemodynamics in heart failure
43. Use of echocardiography in the management of congestive heart failure in the community
44. Congestive heart failure disease management study: A patient education intervention
45. Prevention of hospitalizations for heart failure with an interactive home monitoring program
46. Symptomatic improvement and reduced hospitalization for patients attending a cardiomyopathy clinic
47. Malaligned financial incentives of providers in the treatment of chronic disease: The case of chronic heart failure
48. + transport
49. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease
50. Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge heart antioxidant study (CHAOS)
51. Prolonged beneficial effects of a home-based intervention on unplanned readmissions and mortality among patients with congestive heart failure
52. Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease
53. Beyond drug therapy: Nonpharmacologic care of the patient with advanced heart failure
54. Acute coronary findings at autopsy in heart failure patients with sudden death: Results from the ATLAS trial
55. Early readmission of elderly patients with congestive heart failure
56. Abnormalities of sodium handling and of cardiovascular adaptations during high salt diet in patients with mild heart failure
57. One-year behavioral treatment of obesity: Comparison of moderate and severe caloric restriction and the effects of weight maintenance therapy
58. Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure
59. Does increased access to primary care reduce hospital readmissions?
60. A comprehensive management system for heart failure improves clinical outcomes and reduces medical resource utilization
61. Guidelines for the evaluation and management of heart failure
62. Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: The EPICAL study